Michael Wajnrajch is a board-certified pediatric endocrinologist. He has worked at Pfizer since 2003, and currently is a Senior Medical Director in the Rare Diseases Global Medical Affairs group, responsible for Inborn Errors of Metabolism and Endocrinology at Pfizer.
Dr Wajnrajch is also active in patient care, seeing patients at Bellevue Hospital Center in New York. Dr Wajnrajch is on staff at NYU School of Medicine, holding the title of Clinical Professor of Pediatrics.
Prior to coming to Pfizer and NYU, Dr Wajnrajch was an Associate Professor at Weill Cornell Medical School, active in molecular genetic evaluations of growth abnormalities.